CD74与IL10的mRNA表达与ICU获得性感染风险的关联:一项多中心队列研究
该多中心前瞻性队列纳入725例ICU患者,入院当天(D1)及第3天(D3)、第6天(D6)采集全血,用RT-qPCR检测CD74与IL10的mRNA表达,每日筛查ICU获得性感染(IAI),诊断后数据删失,采用Fine和Gray竞争风险模型分析。137例(19%)发生至少一次IAI。校正入院时休克和脓毒症状态后,CD74 D3/D1表达比值与IAI发生显著相关(亚分布风险比0.67,95%CI 0.46-0.97),IL10 D3表达与IAI发生显著相关(亚分布风险比2.21,95%CI 1.63-3.00)。按CD74或IL10表达分层后,各组IAI累积发生率差异显著(Gray检验P<0.001)。作者认为,这两个免疫生物标志物可能是识别ICU患者IAI风险的相关工具。
要点
- 多中心前瞻性队列纳入725例ICU患者,137例(19%)发生至少一次ICU获得性感染(IAI)。
- 校正入院时休克和脓毒症状态后,CD74 D3/D1表达比值与IAI发生相关,亚分布风险比0.67(95%CI 0.46-0.97)。
- 校正入院时休克和脓毒症状态后,IL10第3天表达与IAI发生相关,亚分布风险比2.21(95%CI 1.63-3.00)。
- 按CD74或IL10表达分层,各组IAI累积发生率差异显著(Gray检验P<0.001)。
- 作者认为CD74和IL10这两个免疫生物标志物可能是识别ICU患者IAI风险的相关工具。
适用人群与场景
- ICU患者,前瞻性纳入多中心队列研究。
研究设计与关键结果
- 研究类型:多中心前瞻性队列研究;共分析725例ICU患者。
- 全血于入院当天(D1)及入院后第3天(D3)、第6天(D6)采集,RT-qPCR检测CD74与IL10的mRNA表达,每日筛查IAI,诊断后数据删失。
- 137例(19%)发生至少一次IAI。
- 校正入院时休克和脓毒症状态后,CD74 D3/D1表达比值与IAI发生的亚分布风险比为0.67(95%CI 0.46-0.97)。
- 校正入院时休克和脓毒症状态后,IL10第3天表达与IAI发生的亚分布风险比为2.21(95%CI 1.63-3.00)。
- 按CD74或IL10表达分层,各组IAI累积发生率差异显著(Gray检验P<0.001)。
证据类型、等级与局限
- 证据类型:多中心前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,CD74和IL10这两个免疫生物标志物可能是识别ICU患者IAI风险的相关工具。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Intensive care unit (ICU)-acquired infections (IAI) result in increased hospital and ICU stay, costs and mortality. To date, no biomarker has shown sufficient evidence and ease of application in clinical routine for the identification of patients at risk of IAI. We evaluated the association of the systemic mRNA expression of two host response biomarkers, CD74 and IL10, with IAI occurrence in a large cohort of ICU patients.
METHODS: ICU patients were prospectively enrolled in a multicenter cohort study. Whole blood was collected on the day of admission (D1) and on day 3 (D3) and day 6 (D6) after admission. Patients were screened daily for IAI occurrence and data were censored after IAI diagnosis. mRNA expression levels of biomarkers were measured using RT-qPCR. Fine and Gray competing risk models were used to assess the association between gene expression and IAI occurrence.
RESULTS: A total of 725 patients were analyzed. At least one IAI episode occurred in 137 patients (19%). After adjustment for shock and sepsis status at admission, CD74 and IL10 levels were found to be significantly associated with IAI occurrence [subdistribution hazard ratio (95% confidence interval) 0.67 (0.46-0.97) for CD74 D3/D1 expression ratio and 2.21 (1.63-3.00) for IL10 at D3]. IAI cumulative incidence was significantly different between groups stratified according to CD74 or IL10 expression (Gray tests p < 0.001).
CONCLUSION: Our results suggest that two immune biomarkers, CD74 and IL10, could be relevant tools for the identification of IAI risk in ICU patients.
参考来源
- Peronnet E, Venet F, Maucort-Boulch D, et al. Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study. Intensive Care Med. 2017. PMID: 28477143. doi:10.1007/s00134-017-4805-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。